AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive Genetic Test
Are you concerned about the possibility of having spastic ataxia type 5? DNA Labs UAE offers a comprehensive genetic test to determine if you carry the AFG3L2 gene mutation associated with this condition.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Before undergoing the AFG3L2 gene spastic ataxia type 5 genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by this autosomal recessive condition.
Test Details
AFG3L2 gene spastic ataxia type 5 is a genetic disorder that is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated AFG3L2 gene, one from each parent, in order to develop the condition.
To confirm a diagnosis of spastic ataxia type 5, a genetic test using Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. It can identify mutations or variations in the AFG3L2 gene that are associated with spastic ataxia type 5.
The NGS genetic test for spastic ataxia type 5 typically involves obtaining a blood or saliva sample from the individual being tested. The DNA in the sample is then sequenced using NGS technology to identify any mutations or variations in the AFG3L2 gene.
The results of the test can help confirm a diagnosis of spastic ataxia type 5 and provide valuable information for genetic counseling and management of the condition.
It is important to note that genetic testing for spastic ataxia type 5 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.
Test Name | AFG3L2 Gene Spastic ataxia type 5 autosomal recessive Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for AFG3L2 Gene Spastic ataxia type 5, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AFG3L2 Gene Spastic ataxia type 5, autosomal recessive |
Test Details |
AFG3L2 gene spastic ataxia type 5 is a genetic disorder that is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated AFG3L2 gene, one from each parent, in order to develop the condition. To confirm a diagnosis of spastic ataxia type 5, a genetic test using Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. It can identify mutations or variations in the AFG3L2 gene that are associated with spastic ataxia type 5. The NGS genetic test for spastic ataxia type 5 typically involves obtaining a blood or saliva sample from the individual being tested. The DNA in the sample is then sequenced using NGS technology to identify any mutations or variations in the AFG3L2 gene. The results of the test can help confirm a diagnosis of spastic ataxia type 5 and provide valuable information for genetic counseling and management of the condition. It is important to note that genetic testing for spastic ataxia type 5 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support. |